Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026| (NASDAQ: AMLX) | Delayed: 32.39 -0.02 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.41 | 52 Week High | $ | |||
| Open | $32.55 | 52 Week Low | $ | |||
| Day High | $33.16 | P/E | N/A | |||
| Day Low | $31.90 | EPS | $ | |||
| Volume | 1,005,646 | |||||

